These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 23252944

  • 1. Effect of GRK4 genetic variants on blood pressure response to atenolol and cardiovascular outcomes.
    Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.
    Pharmacogenomics; 2013 Jan; 14(1):13-4. PubMed ID: 23252944
    [No Abstract] [Full Text] [Related]

  • 2. Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
    Nordestgaard BG, Kontula K, Benn M, Dahlöf B, de Faire U, Edelman JM, Eliasson E, Fyhrquist F, Hille DA, Ibsen H, Lyle PA, Berg K, Sandberg M, Sethi AA, Wong PH, Os I.
    Pharmacogenet Genomics; 2010 Feb; 20(2):77-85. PubMed ID: 20065889
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, Collier D, Dicker P, O'Brien E, ASCOT Investigators.
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [Abstract] [Full Text] [Related]

  • 4. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH.
    Ugeskr Laeger; 2003 Jan 27; 165(5):456-9. PubMed ID: 12599843
    [Abstract] [Full Text] [Related]

  • 5. Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade.
    Hassan NA, Gunaid AA, El-Khally FM, Al-Noami MY, Murray-Lyon IM.
    Saudi Med J; 2005 Apr 27; 26(4):537-41. PubMed ID: 15900355
    [Abstract] [Full Text] [Related]

  • 6. Characterization of G protein-coupled receptor kinase 4 and measuring its constitutive activity in vivo.
    Andresen BT.
    Methods Enzymol; 2010 Apr 27; 484():631-51. PubMed ID: 21036254
    [Abstract] [Full Text] [Related]

  • 7. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.
    Blood Press; 2007 Apr 27; 16(1):6-12. PubMed ID: 17453746
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients.
    Orlandi C, Fogari R.
    Clin Ther; 1983 Apr 27; 5(6):632-7. PubMed ID: 6627289
    [Abstract] [Full Text] [Related]

  • 9. Time-related effects of chronic atenolol treatment on cardiovascular responses to handgrip.
    Fogari R, Zoppi A, Orlandi C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb 27; 23(2):83-8. PubMed ID: 3988399
    [Abstract] [Full Text] [Related]

  • 10. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NR, ASCOT Investigators.
    J Am Coll Cardiol; 2009 Sep 22; 54(13):1154-61. PubMed ID: 19761936
    [Abstract] [Full Text] [Related]

  • 11. Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Ruwald AC, Westergaard B, Sehestedt T, Kjeldsen SE, Lindholm LH, Wachtell K, Devereux RB, Ibsen H, Nieminen MS, Dahlöf B, Olsen MH.
    J Hypertens; 2012 Jun 22; 30(6):1252-9. PubMed ID: 22499288
    [Abstract] [Full Text] [Related]

  • 12. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A, Salkar H, Mulay P, Desai S, Chandurkar N, Redkar N.
    Am J Ther; 2010 Jun 22; 17(1):46-52. PubMed ID: 19535971
    [Abstract] [Full Text] [Related]

  • 13. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
    Ibsen H, Lindholm LH, Pedersen OL, Dahlöf B, Kjeldsen S.
    Ugeskr Laeger; 2003 Jan 27; 165(5):459-62. PubMed ID: 12599844
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 27; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 15. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM, Aranda JM, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, Hewkin A, Pepine CJ, INVEST Investigators.
    Am Heart J; 2006 May 27; 151(5):1072-9. PubMed ID: 16644338
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
    Tapp RJ, Sharp A, Stanton AV, O'Brien E, Chaturvedi N, Poulter NR, Sever PS, Thom SA, Hughes AD, Mayet J, ASCOT Investigators.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1875-81. PubMed ID: 20413040
    [Abstract] [Full Text] [Related]

  • 17. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
    Attwood S, Bird R, Burch K, Casadei B, Coats A, Conway J, Dawes M, Ebbs D, Farmer A, Robinson J.
    J Hypertens; 1994 Sep 27; 12(9):1053-60. PubMed ID: 7852749
    [Abstract] [Full Text] [Related]

  • 18. [Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
    Cannella G, Picotti GB, Giambelli A, Scolari F, Cesura AM, Tosoni S, Maiorca R.
    G Ital Cardiol; 1982 Sep 27; 12(12):884-8. PubMed ID: 6763907
    [Abstract] [Full Text] [Related]

  • 19. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril.
    Bursztyn M, Gavras I, Gourley L, DeSilva J, Whalen J, Gavras H.
    Clin Ther; 1994 Sep 27; 16(3):429-36. PubMed ID: 7923309
    [Abstract] [Full Text] [Related]

  • 20. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR, Marchione CS.
    J Pharmacol Exp Ther; 1989 Nov 27; 251(2):599-605. PubMed ID: 2572694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.